Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Huntingtons Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Huntingtons Disease Therapeuticsmarket, defines the market attractiveness level of Huntingtons Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Huntingtons Disease Therapeutics industry, describes the types of Huntingtons Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Huntingtons Disease Therapeutics market and the development prospects and opportunities of Huntingtons Disease Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Huntingtons Disease Therapeutics market in Chapter 13.
By Player:
Alnylam Pharmaceuticals
Auspex Pharmaceuticals
Vertex Pharmaceuticals
Raptor Pharmaceuticals
Valeant Pharmaceuticals International
Intellect Neurosciences Incorporation
H Lundbeck
Sangamo Biosciences
Trophos SA
Prana Biotechnology Limited
Teva Pharmaceutical Industries
Roche
By Type:
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
By End-User:
Hosptial
Clinic
Research
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Huntingtons Disease Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Huntingtons Disease Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Huntingtons Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Huntingtons Disease Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Huntingtons Disease Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Huntingtons Disease Therapeutics Consumption (2017-2022)
-
7.2 United States Huntingtons Disease Therapeutics Consumption (2017-2022)
-
7.3 Europe Huntingtons Disease Therapeutics Consumption (2017-2022)
-
7.4 China Huntingtons Disease Therapeutics Consumption (2017-2022)
-
7.5 Japan Huntingtons Disease Therapeutics Consumption (2017-2022)
-
7.6 India Huntingtons Disease Therapeutics Consumption (2017-2022)
-
7.7 South Korea Huntingtons Disease Therapeutics Consumption (2017-2022)
8 Region and Country-wise Huntingtons Disease Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Huntingtons Disease Therapeutics Consumption Forecast (2022-2028)
9 Global Huntingtons Disease Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Huntingtons Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antidopaminergics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antidepressants Consumption and Growth Rate (2017-2022)
-
9.2 Global Huntingtons Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hosptial Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Consumption and Growth Rate (2017-2022)
10 Global Huntingtons Disease Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antidopaminergics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hosptial Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Consumption Forecast and Growth Rate (2022-2028)
11 Global Huntingtons Disease Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Huntingtons Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Huntingtons Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Huntingtons Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Huntingtons Disease Therapeutics Market Competitive Analysis
-
14.1 Alnylam Pharmaceuticals
-
14.1.1 Alnylam Pharmaceuticals Company Details
-
14.1.2 Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
14.2 Auspex Pharmaceuticals
-
14.2.1 Auspex Pharmaceuticals Company Details
-
14.2.2 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
14.3 Vertex Pharmaceuticals
-
14.3.1 Vertex Pharmaceuticals Company Details
-
14.3.2 Vertex Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Vertex Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
14.4 Raptor Pharmaceuticals
-
14.4.1 Raptor Pharmaceuticals Company Details
-
14.4.2 Raptor Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Raptor Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
14.5 Valeant Pharmaceuticals International
-
14.5.1 Valeant Pharmaceuticals International Company Details
-
14.5.2 Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Product and Service
-
14.6 Intellect Neurosciences Incorporation
-
14.6.1 Intellect Neurosciences Incorporation Company Details
-
14.6.2 Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Product and Service
-
14.7 H Lundbeck
-
14.7.1 H Lundbeck Company Details
-
14.7.2 H Lundbeck Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 H Lundbeck Huntingtons Disease Therapeutics Product and Service
-
14.8 Sangamo Biosciences
-
14.8.1 Sangamo Biosciences Company Details
-
14.8.2 Sangamo Biosciences Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sangamo Biosciences Huntingtons Disease Therapeutics Product and Service
-
14.9 Trophos SA
-
14.9.1 Trophos SA Company Details
-
14.9.2 Trophos SA Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Trophos SA Huntingtons Disease Therapeutics Product and Service
-
14.10 Prana Biotechnology Limited
-
14.10.1 Prana Biotechnology Limited Company Details
-
14.10.2 Prana Biotechnology Limited Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Prana Biotechnology Limited Huntingtons Disease Therapeutics Product and Service
-
14.11 Teva Pharmaceutical Industries
-
14.11.1 Teva Pharmaceutical Industries Company Details
-
14.11.2 Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Product and Service
-
14.12 Roche
-
14.12.1 Roche Company Details
-
14.12.2 Roche Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Roche Huntingtons Disease Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Huntingtons Disease Therapeutics
-
Figure Huntingtons Disease Therapeutics Picture
-
Table Global Huntingtons Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Huntingtons Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Huntingtons Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Huntingtons Disease Therapeutics Consumption by Country (2017-2022)
-
Figure United States Huntingtons Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Huntingtons Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Huntingtons Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Huntingtons Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Huntingtons Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Huntingtons Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Huntingtons Disease Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Huntingtons Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidopaminergics Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Hosptial Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Consumption and Growth Rate (2017-2022)
-
Figure Global Antidopaminergics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hosptial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Huntingtons Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Huntingtons Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
Table Auspex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Auspex Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Auspex Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
Table Raptor Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Raptor Pharmaceuticals Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Raptor Pharmaceuticals Huntingtons Disease Therapeutics Product and Service
-
Table Valeant Pharmaceuticals International (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Product and Service
-
Table Intellect Neurosciences Incorporation (Foundation Year, Company Profile and etc.)
-
Table Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Product and Service
-
Table H Lundbeck (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck Huntingtons Disease Therapeutics Product and Service
-
Table Sangamo Biosciences (Foundation Year, Company Profile and etc.)
-
Table Sangamo Biosciences Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Biosciences Huntingtons Disease Therapeutics Product and Service
-
Table Trophos SA (Foundation Year, Company Profile and etc.)
-
Table Trophos SA Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trophos SA Huntingtons Disease Therapeutics Product and Service
-
Table Prana Biotechnology Limited (Foundation Year, Company Profile and etc.)
-
Table Prana Biotechnology Limited Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prana Biotechnology Limited Huntingtons Disease Therapeutics Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Huntingtons Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Huntingtons Disease Therapeutics Product and Service
-
